Byong Park
Internal Medicine · Lyndhurst, NJNPI 1235104506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Amgen at 27.6% of the total. Reporting peaked in 2019 at $809 and has fallen 97.8% since, to $18 in 2025.
Across 74 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$320
- Lilly USA, LLC$177
- Novo Nordisk$76
- Indivior Inc.$72
- Medtronic$53
- AbbVie$51
- plus $412 from 17 others
What the payments were for
- Food & beverage$1,14999%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $320 |
| Lilly USA, LLC | 13 | $177 |
| Novo Nordisk | 5 | $76 |
| Indivior Inc. | 5 | $72 |
| Medtronic | 1 | $53 |
| AbbVie | 4 | $51 |
| Boehringer Ingelheim | 3 | $45 |
| Valeritas, Inc. | 3 | $42 |
| Amarin Pharma, Inc. | 3 | $41 |
| Gilead | 3 | $38 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| GSK | 2 | $29 |
| Scilex Pharmaceuticals Inc. | 2 | $28 |
| Merck | 2 | $26 |
| Pfizer | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $15 |
| Lupin Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| BD | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Phadia US Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$125
How this compares
$1,161 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 26 | $7,370 |
| Cyclosporine | 24 | $4,754 |
| Nifedipine ErNifedipine | 12 | $279 |
| Rosuvastatin Calcium | 14 | $251 |
| Losartan Potassium | 21 | $232 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $226 |
| Amlodipine Besylate | 25 | $185 |
| Metoprolol Succinate | 17 | $184 |
| Gabapentin | 16 | $110 |
| Hydrochlorothiazide | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lyndhurst
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.